The chemistry and biological activity of heterocycle-fused quinolinone derivatives: A review

被引：140

作者：

Shiro, Tomoya ^{[1
]}

Fukaya, Takayuki ^{[1
]}

Tobe, Masanori ^{[1
]}

机构：

[1] Sumitomo Dainippon Pharma Co Ltd, Drug Res Div, Suita, Osaka 5640053, Japan

来源：

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2015年 / 97卷

关键词：

Quinolinone; Quinolin-4-one; Heterocycles; MUSCARINIC ACETYLCHOLINE-RECEPTORS; PROSTAGLANDIN E-2 SYNTHASE; PEPTIDASE-IV INHIBITOR; POSITIVE ALLOSTERIC MODULATOR; GLUCAGON-LIKE PEPTIDE-1; HIGHLY POTENT; MICE LACKING; DISCOVERY; HEDGEHOG; AMPA;

D O I：

10.1016/j.ejmech.2014.12.004

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Among all heterocycles, the heterocycle-fused quinolinone scaffold is one of the privileged structures in drug discovery as heterocycle-fused quinolinone derivatives exhibit various biological activities allowing them to act as anti-inflammatory, anticancer, antidiabetic, and antipsychotic agents. This wide spectrum of biological activity has attracted a great deal of attention in the field of medicinal chemistry. In this review, we provide a comprehensive description of the biological and pharmacological properties of various heterocycle-fused quinolinone scaffolds and discuss the synthetic methods of some of their derivatives. (C) 2014 Elsevier Masson SAS. All rights reserved.

引用

页码：397 / 408

页数：12

共 77 条

[1] Expression of cGMP-specific phosphodiesterase 9A mRNA in the rat brain [J].

Andreeva, SG ;

Dikkes, P ;

Epstein, PM ;

Rosenberg, PA .

JOURNAL OF NEUROSCIENCE, 2001, 21 (22) :9068-9076

[2]

[Anonymous], 2012, VISM ER PRESCR INF

[3] Discovery and SAR of PF-4693627, a potent, selective and orally bioavailable mPGES-1 inhibitor for the potential treatment of inflammation [J].

Arhancet, Graciela B. ;

Walker, Daniel P. ;

Metz, Sue ;

Fobian, Yvette M. ;

Heasley, Steven E. ;

Carter, Jeffrey S. ;

Springer, John R. ;

Jones, Darin E. ;

Hayes, Michael J. ;

Shaffer, Alexander F. ;

Jerome, Gina M. ;

Baratta, Michael T. ;

Zweifel, Ben ;

Moore, William M. ;

Masferrer, Jaime L. ;

Vazquez, Michael L. .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (04) :1114-1119

[4]

Asano J., 2001, PCT Int. Appl., Patent No. [WO0146190, 0146190]

[5]

Auberson Y., 2011, PCT Int. Appl, Patent No. [WO2011144666, 2011144666]

[6] Discovery and preclinical profile of saxagliptin (BMS-477118): A highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes [J].

Augeri, DJ ;

Robl, JA ;

Betebenner, DA ;

Magnin, DR ;

Khanna, A ;

Robertson, JG ;

Wang, AY ;

Simpkins, LM ;

Taunk, P ;

Huang, Q ;

Han, SP ;

Abboa-Offei, B ;

Cap, M ;

Xin, L ;

Tao, L ;

Tozzo, E ;

Welzel, GE ;

Egan, DM ;

Marcinkeviciene, J ;

Chang, SY ;

Biller, SA ;

Kirby, MS ;

Parker, RA ;

Hamann, LG .

JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (15) :5025-5037

[7] New 2-arylpyrazolo[4,3-c]quinoline derivatives as potent and selective human A3 adenosine receptor antagonists [J].

Baraldi, PG ;

Tabrizi, MA ;

Preti, D ;

Bovero, A ;

Fruttarolo, F ;

Romagnoli, R ;

Zaid, NA ;

Moorman, AR ;

Varani, K ;

Borea, PA .

JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (15) :5001-5008

[8] Tissue repair and stem cell renewal in carcinogenesis [J].

Beachy, PA ;

Karhadkar, SS ;

Berman, DM .

NATURE, 2004, 432 (7015) :324-331

[9] CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES - FUNCTIONAL IMPLICATIONS OF MULTIPLE ISOFORMS [J].

BEAVO, JA .

PHYSIOLOGICAL REVIEWS, 1995, 75 (04) :725-748

[10] Synthesis and structure-activity relationships of 1,2,3,4-tetrahydroquinoline-2,3,4-trione 3-oximes: Novel and highly potent antagonists for NMDA receptor glycine site [J].

Cai, SX ;

Zhou, ZL ;

Huang, JC ;

Whittemore, ER ;

Egbuwoku, ZO ;

Lu, YX ;

Hawkinson, JE ;

Woodward, RM ;

Weber, E ;

Keana, JFW .

JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (17) :3248-3255

← 1 2 3 4 5 6 7 8 →